State of New Jersey Common Pension Fund D Has $2.11 Million Position in Sotera Health (NASDAQ:SHC)

State of New Jersey Common Pension Fund D raised its position in shares of Sotera Health (NASDAQ:SHC - Free Report) by 21.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 154,237 shares of the company's stock after purchasing an additional 27,247 shares during the quarter. State of New Jersey Common Pension Fund D owned about 0.05% of Sotera Health worth $2,110,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SHC. Louisiana State Employees Retirement System boosted its stake in Sotera Health by 20.5% during the 3rd quarter. Louisiana State Employees Retirement System now owns 42,400 shares of the company's stock valued at $708,000 after purchasing an additional 7,200 shares in the last quarter. Wealth Enhancement Advisory Services LLC bought a new stake in shares of Sotera Health during the 3rd quarter worth $850,000. State of Alaska Department of Revenue boosted its stake in shares of Sotera Health by 31.7% during the 3rd quarter. State of Alaska Department of Revenue now owns 17,760 shares of the company's stock worth $296,000 after acquiring an additional 4,270 shares in the last quarter. Pallas Capital Advisors LLC bought a new stake in shares of Sotera Health during the 3rd quarter worth $334,000. Finally, New York State Teachers Retirement System boosted its stake in shares of Sotera Health by 3.5% during the 3rd quarter. New York State Teachers Retirement System now owns 53,500 shares of the company's stock worth $893,000 after acquiring an additional 1,800 shares in the last quarter. 91.03% of the stock is owned by institutional investors.

Sotera Health Stock Up 0.9 %

NASDAQ SHC traded up $0.13 during trading on Monday, hitting $13.65. 224,282 shares of the company traded hands, compared to its average volume of 850,462. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The business has a fifty day simple moving average of $13.45 and a 200 day simple moving average of $14.56. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The company has a market capitalization of $3.86 billion, a P/E ratio of 54.58 and a beta of 1.91.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on SHC shares. Barclays reduced their price objective on Sotera Health from $18.00 to $17.00 and set an "overweight" rating for the company in a research note on Tuesday, February 18th. Royal Bank of Canada reissued an "outperform" rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Citigroup increased their target price on Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a report on Wednesday, November 6th. Finally, The Goldman Sachs Group initiated coverage on Sotera Health in a report on Friday, December 6th. They issued a "neutral" rating and a $14.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Sotera Health has a consensus rating of "Moderate Buy" and an average price target of $16.08.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.